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Summary
The central circadian pacemaker of the suprachiasmatic
nucleus (SCN) is characterized as a series of transcrip-
tional/posttranslational feedback loops [1, 2]. How this
molecular mechanism coordinates daily rhythms in the
SCN and hence the organism is poorly understood. We con-
ducted the first systematic exploration of the ‘‘circadian
intracellular proteome’’ of the SCN and revealed thatw13%
of soluble proteins are subject to circadian regulation.
Many of these proteins have underlying nonrhythmic
mRNAs, so they have not previously been noted as circa-
dian. Circadian proteins of the SCN include rate-limiting
factors in metabolism, protein trafficking, and, intriguingly,
synaptic vesicle recycling. We investigated the role of this
clock-regulated pathway by treating organotypic cultures
of SCN with botulinum toxin A or dynasore to block exocy-
tosis and endocytosis. These manipulations of synaptic
vesicle recycling compromised circadian gene expression,
both across the SCN as a circuit and within individual SCN
neurons. These findings reveal how basic cellular processes
within the SCN are subject to circadian regulation and how
disruption of these processes interferes with SCN cellular
pacemaking. Specifically, we highlight synaptic vesicle
cycling as a novel point of clock cell regulation in mammals.Results
Circadian pacemaking in the suprachiasmatic nucleus (SCN),
the principal coordinator of circadian rhythms in mammals,
arises from interlocked transcriptional/posttranslational feed-
back loops [1, 2]. Circadian signaling between SCN neurons
and their targets relies upon daily cycles of electrical firing
and neurosecretion. How the molecular clock drives these
output rhythms is unclear, although transcriptional profiling*Correspondence: ksl23@cam.ac.uk (K.S.L.), mha@mrc-lmb.cam.ac.uk
(M.H.H.)
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CB10 1SA, UKhas identified a number of circadian-regulated genes in
the SCN [3, 4], while proteomic approaches have identified
extracellular, secretory products of the SCN [5]. Here, we
conducted a systematic exploration of the SCN ‘‘circadian
proteome’’ via two-dimensional difference gel electrophoresis
(2D-DIGE) combined with mass spectrometry (MS) to identify
intracellular factors likely to contribute to circadian time-
keeping in the SCN. The utility of this approach has been
demonstrated in previous analyses of the hepatic circadian
proteome [6, 7].
Soluble proteins were displayed by 2D-DIGE with SCN
tissue harvested from mice on the second cycle after transfer
from 12 hr light and 12 hr dim red light to constant dim red light.
Proteins were extracted from two SCN per replicate, with six
replicates at each of four circadian times (CT) (CT0, 6, 12,
and 18; n = 12 mice per time point; n = 48). Applying this exper-
imental design and previously described criteria [6, 7], 871
protein ‘‘spots’’ were reliably detected across gels (see Fig-
ure S1 available online). Of these, 115 exhibited a statistically
significant change over circadian time (analysis of variance
[ANOVA], p < 0.05), and we focused on 53 spots with a clear
circadian profile in which abundance changed significantly
between samples 12 hr apart (Figure S2). Peak abundances
of these spots extended across the cycle, with more peaks
during circadian day (65%) than night (35%). We estimate
that between 6% (53 of 871) and 13% (115 of 871) of robustly
expressed soluble SCN proteins are under circadian regula-
tion. This compares with previous estimates of the SCN circa-
dian transcriptome (w5% of genes assayed [3]), whereas in
the liver, 10%–20% of detectable proteins were under circa-
dian regulation [7].
The original gels and two further series of preparative gels
from independent SCN samples were analyzed by generating
uninterpreted peptide fragmentation data via liquid chroma-
tography followed by tandem mass spectrometry (LC-MS/
MS) and by using the Mascot search engine. In several cases,
different rhythmic spots represented isoforms of the same
protein, but ultimately we identified 34 proteins as circadian
regulated (see Table 1 for an annotated list). These repre-
sented several functional categories, including cellular metab-
olism (glutamate dehydrogenase 1, enolase, M2-pyruvate
kinase, NADP-dependent isocitrate dehydrogenase, aldolase,
3-oxoacid CoA transferase 1) and heat-shock proteins (heat-
shock proteins 1a, 8, 9A, and 84 kDa and chaperone subunit
53) (Figures 1A and 1B). Significantly, factors associated with
synaptic vesicle cycling were also rhythmic, including N-ethyl-
maleimide-sensitive fusion protein (NSF), the binding protein
for NSF (SNAP-b), two isoforms of synapsin II, and the zeta iso-
form of the 14-3-3 scaffolding protein (Figure 1C). Whereas
other family members, synapsin I and SNAP-25, have mRNAs
that cycle in the SCN [4], it was evident that none of our puta-
tive circadian proteins have been associated with rhythmic
SCN mRNA expression [3, 4]. To cross-validate this unex-
pected finding, an independent series of SCN samples were
subjected to quantitative polymerase chain reaction (PCR).
In this sample set, the canonical clock genes Per1, Per2, and
Rev-erba exhibited significant changes over time, as did
the circadian output gene Dbp (Figures 1D–1F; Table S1).
Table 1. Circadian Proteins of Suprachiasmatic Nucleus Revealed by
DIGE/MS
Spot
Number Protein ID MW
Mascot
Score
Unique
Peptides
367 309317 84 kDa heat-shock protein 83638 356 6
369 6754354 Heat-shock protein 1,
alpha
85134 123 2
573 1171774 Vesicle-fusing ATPase
(vesicular-fusion
protein NSF)
83083 686 15
638 440121 Immunoglobin gamma
chain
51545 156 3
664 6754256 Heat-shock protein 9A 73768 1279 22
680 42542422 Heat-shock protein 8 71056 1580 32
744 599966 TOAD-64 62638 740 14
762 8567410 Synapsin II 52818 238 4
797 14389431 Stress-induced
phosphoprotein
63156 677 20
920 6671702 Chaperone subunit 5
(epsilon)
60042 582 14
921 110625624 t complex protein 60867 1324 21
937 17390900 Ina protein 55520 756 17
1008 6679687 Protein disulphide
isomerase associated 3
57042 648 11
1011 1405933 M2-pyruvate kinase 58448 993 20
1082 8567410 Synapsin II 52818 291 5
1091 13097345 3-oxoacid CoA
transferase 1
56352 655 10
1175 30931187 Glutamate
dehydrogenase 1
61640 640 12
1191 38328220 Sept11 protein 49991 124 3
1279 13097429 Methionine
adenosyltransferase II,
alpha
44003 169 3
1326 54114937 Eno1 protein 50165 540 11
1363 15929689 Creatine kinase 42985 249 5
1408 27370092 Tu translation
elongation factor,
mitochondrial
44003 169 3
1506 3631400 NADP-dependent
isocitrate dehydrogenase
47030 535 12
1622 160298209 Glutamate oxoloacetate
transaminase 1
42232 602 11
1644 7548322 Aldolase A 39925 599 13
1647 7548322 Aldolase A 39925 659 13
1656 7548322 Aldolase A 39925 648 10
1864 54611730 NSF attachment
protein beta
33878 361 7
1901 13097375 Electron transferring
protein
35360 230 5
2043 1841387 14-3-3 zeta 27879 444 8
2071 12805413 Eschs1 protein 31636 258 6
2079 6755198 Proteasome subunit,
alpha type 6
27811 258 5
2210 28436836 Triosephosphate
isomerase 1
27038 471 12
2147 94371142 Predicted: similar to
glutathione S-transferase
25864 264 5
2216 21465838 Chain C, guanine
nucleotide exchange
region of intersectin
21189 105 2
2327 53237015 Peptidylprolyl
isomerase A
18131 312 7
Spot number refers to arbitrary numbering of features within the 2D gel field
recognizable throughout the study.
Current Biology Vol 19 No 23
2032Expression of Cry1 failed narrowly to reach significance by
ANOVA. Of the 21 genes encoding putative circadian proteins
tested in this way, only 3 (11%) showed significantly circadian
mRNA expression in the SCN (Figures 1D–1F; Table S1). Thiscontrasts with significant circadian expression exhibited by 8
of the 18 (44%) of these genes expressed in the liver (data
not shown). To probe further for low-amplitude mRNA
rhythms, we reanalyzed the data by cross-correlation to a
24 hr sinusoid (see Supplemental Experimental Procedures),
which revealed a statistically significant cycle in Cry1 expres-
sion (Table S1) and 8 (38%) of the other 21 genes. Hence,
depending on the analysis used, between 11% and 38% of
the rhythmic proteins are accompanied by significantly
rhythmic mRNA. As with the liver, where w50% of rhythmic
proteins were accompanied by nonrhythmic mRNAs [7], we
conclude that posttranscriptional regulation is a significant
feature in circadian sculpting of the SCN proteome.
Circadian regulation of metabolic factors parallels the well-
characterized circadian cycle of glucose utilization in the
SCN [8]. Circadian modulation of vesicle and membrane recy-
cling proteins, however, was unprecedented. We therefore
explored the functional significance of these clock-regulated
factors in circadian pacemaking. Synapsins are neuron-
specific phosphoproteins exclusively associated with small
synaptic vesicle membranes and actin filaments at the syn-
aptic terminal. Synapsin II controls the reserve pool of synaptic
vesicles [9] and has been implicated in the etiology or patho-
genesis of schizophrenia [10]. The 14-3-3z adaptor protein
associates with various neural signaling pathways [11] and
again regulates exocytosis by controlling the releasable
vesicle pool [12]. The ATPase NSF directs the formation of
soluble NSF attachment protein receptor (SNARE) complexes,
initiating endocytosis of fused synaptic vesicles from the
presynaptic membrane and vesicle fusion preceding neuro-
transmitter release [13]. The binding of NSF to SNARE
complexes is facilitated by NSF attachment proteins (SNAPs)
[14], the beta isoform being brain specific and, as with NSF,
implicated in both exocytosis and endocytosis [15]. In the
SCN, NSF and synapsin II were coregulated with comparable
circadian profiles and peak abundance during circadian day,
whereas levels of 14-3-3z and SNAP-b were lowest at CT12
(Figure 1C). We confirmed SCN expression of NSF and synap-
sin by immunocytochemistry and western blots, with clear
punctate signals evident by immunostain and single (NSF)
and double (synapsin) bands by western blot. Despite exhaus-
tive testing, however, we could detect no temporal change in
expression (Figure S3). This might arise if multiple isoforms
were expressed, only some of which were clock regulated.
We therefore performed 2D-DIGE/MS on a further series of
samples to identify potential nonrhythmic isoforms, evident,
for example, as a charge train of adjacent spots. This revealed
a second NSF spot (571), which was not statistically rhythmic
and had a profile different from that of the circadian isoform
(spot 573, Figures 2A and 2D). The nonrhythmic isoform
appeared at the same molecular weight but was more acidic
than its counterpart, indicating posttranscriptional or post-
translational processing. Similarly, three further isoforms of
synapsin II were identified, none of which exhibited significant
effects of time but each of which were nonetheless expressed
at peak levels later than the rhythmic spots (Figures 2B, 2C,
and 2E). One nonrhythmic isoform had a similar molecular
weight to its rhythmic counterpart but had an increased
pI (Figure 2B). A larger rhythmic isoform also had two non-
rhythmic counterparts of similar molecular weight, one more
acidic, the other more basic (Figure 2C). These results empha-
size the temporal complexity of synaptic vesicle protein
expression in the SCN arising from circadian transcriptional/
posttranslational processing. They also reinforce the value of
A B C
2.0
1.2
0.4
0 6 12 18 00 6 12 18 0 0 6 12 18
Circadian time
0
Circadian time
0 6 12 18 0 0 6 12 18 0 0 6 12 18 0
R
el
at
iv
e 
ab
un
da
nc
e
pr
ot
ei
n
D E F
R
el
at
iv
e 
ab
un
da
nc
e
m
R
N
A
2.0
1.2
0.4
2.0
1.2
0.4
Figure 1. Circadian Metabolic and Vesicle-
Cycling Proteins in Suprachiasmatic Nucleus
Identified by DIGE/MS Are Accompanied by Non-
circadian mRNA Expression
(A–C) Representative plots of significantly
rhythmic proteins with peak phases at either (A)
circadian dusk (red, synapsin II [spot 762]; blue,
glutamate dehydrogenase; dark green, sept 11
protein; light green, stress-induced phosphopro-
tein) or (B) circadian dawn (red, neuronal inter-
nexin; blue, chaperone subunit 5; dark green,
t complex protein; light green, heat-shock protein
8) and (C) proteins involved in synaptic vesicle
cycling (red, synapsin II [spot 1082]; blue, N-eth-
ylmaleimide-sensitive fusion protein [NSF];
dark green, NSF attachment protein; light green,
14-3-3z).
(D–F) Circadian expression of mRNAs encoding
canonical clock factors but absence of circadian
expression of mRNAs encoding rhythmic
proteins in suprachiasmatic nucleus (SCN): (D)
black = Per1, red = neuronal internexin, blue =
chaperone subunit 5, green = heat-shock protein
8; (E) black = Per2, red = synapsin II, blue = NSF,
green = NSF attachment protein; (F) black = Dbp, blue = glutamate dehydrogenase, dark green = sept 11 protein, light green = stress-induced phosphopro-
tein. All data plotted as mean + standard error of the mean (SEM); n = 3–6 per time point; CT0 replotted for clarity.
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20332D-DIGE/MS in identifying individually rhythmic isoforms that
would otherwise be overlooked.
To investigate the role of synaptic vesicle cycling in cellular
and circuit pacemaking, we treated organotypic SCN slices
with either dynasore [16], a small-molecule inhibitor of dyna-
min and hence an inhibitor of endocytosis, or botulinum toxin
A (Botox A), an inhibitor of exocytosis [17]. Inevitably, by inter-
fering with one phase of vesicle cycling, these treatments
would ultimately perturb both. Therefore, by comparing the
effects of Botox A and dynasore, we hypothesized that we
would be able to reveal the global contribution of vesicle
cycling to the SCN clockwork. Circadian gene expression
across the SCN and within individual SCN cells was monitored
by three independent optical reporters [18]. The mPer1::
dsEGFP transgene provides a fluorescent signal of transcrip-
tional activation of the Per1 gene [19], whereas the mPer1::
luciferase transgene provides a bioluminescent report ofNSF (rhythmic, 573)
NSF (nonrhythmic, 571)
Synapsin Ib (non-
rhythmic, 564)
Synapsin II (rhythmic, 1082)
Synapsin II (nonrhythmic, 1079)
Synapsin II
Synapsin II (n
Syna
A B C
NSF original spot 573, new spot 571 
0 6 12 18
Circadian time
0
D
Synapsin II original spot 1082
0 6 1
Circad
E
Transferrin (nonrhythmic, 563)mPer1 activation [20]. Tissues from the mPer2::luciferase
knockin mouse provide a bioluminescent report for Per2 pro-
tein cycling [21]. Previous characterization has confirmed that,
in the SCN, these signals are neuronal rather than glial in origin.
Vehicle had no effect on circadian gene expression in SCN
slices, whereas dynasore significantly reduced the amplitude
of mPer1::dsEGFP fluorescence to approximately one-third
that of control (Figure 3A; Figure 4A). Video microscopy
showed that the effect of dynasore was evident in individual
neurons across the SCN (Figure 4B). Dynasore also inhibited
circadian transcription in mPer1::luciferase slices, where the
baseline level of bioluminescence immediately fell and the
amplitude of oscillation was reduced to w50% of control.
This effect was reversible, the oscillation in mPer1-driven
bioluminescence being restored on washout (Figure 3B).
Treatment with dynasore also caused significant damping in
the rhythm of Per2 protein expression by w30% (Figure 3C (rhythmic, 762)
onrhythmic, 751)
psin II (nonrhythmic, 758)
, new spots 758, 1079, 751
2 18
ian time
0
Figure 2. DIGE/MS Reveals Multiple Isoforms of
NSF and Synapsin in SCN
(A–C) Magnified views of two-dimensional differ-
ence gel electrophoresis (2D-DIGE) gels showing
(A) NSF isoforms and (B) isoforms of synapsin II
at approximately 58 kDa and (C) isoforms of syn-
apsin II at approximately 86 kDa. Spots marked
with a red circle are nonrhythmic.
(D and E) Circadian profiles of rhythmic and non-
rhythmic isoforms of NSF and synapsins identi-
fied by DIGE/mass spectrometry (MS) (mean +
SEM; CT0 replotted for clarity).
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Figure 3. Compromised Circadian Pacemaking in Organotypic SCN Slices
in which Vesicle Recycling Is Dysregulated by Treatment with Dynasore
or Botox A
Representative recordings of circadian gene expression from SCN slices
carrying (A) mPer1::EGFP, (B) mPer1::luciferase, or (C) mPer2::luciferase
reporter genes, treated with either vehicle (arrow, left), dynasore (80 mM,
center), or Botox A (6.7 nM, right), monitored by (A) video-fluorescence
microscopy or (B and C) photomultiplier assembly.
mPer1::GFP mPER2::luciferasemPer1::luciferase
**
**
**
A
m
pl
itu
de
 c
irc
ad
ia
n 
ge
ne
ex
pr
es
si
on
, p
er
ce
nt
 
in
iti
al
25
50
75
100
ND
untreated vehicle Dynasore BotoxA Botox A
NDND
**
**
**
A
CB
Circadian reporter gene
Pretreat
With Botox A
Trough Peak
25
26
24P
er
io
d,
 h
ou
rs
Vehicle Botox A, 6.7 nM
**
NS
Figure 4. Acute Inhibition of Endocytosis and Exocytosis Damps Circadian
Gene Expression and Prolongs Circadian Period in Organotypic SCN Slices
(A) Group data reveal significant suppression of circadian gene expression
cycles in SCN treated with dynasore (80 mM) or Botox A (dark gray 6.7 nM,
black 67 nM). All data plotted as mean + SEM; n = 3–7; ND = not determined.
(B) Representative fluorescence images of mPer1::EGFP SCN slices before
and after treatment with Botox A (67 nM) reveal loss of peak signal (arrow,
scale bar represents 500 mm).
(C) Circadian period of bioluminescent gene expression rhythms in SCN
(mean + SEM) before (white columns) and after treatment with either vehicle
(gray column) or Botox A (black column). **p < 0.01 versus untreated control
condition; NS = not significant.
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2034and Figure 4A). Hence, circadian gene expression in the SCN
pacemaker, as monitored by three independent reporters,
was disrupted by interference with vesicle cycling.
Botox A had an even more dramatic effect upon circadian
pacemaking. It acutely suppressed the amplitude of oscillation
by 50%–75%, both across the SCN as a whole and within indi-
vidual SCN neurons monitored with either mPer1::dsEGFP or
mPer2::luciferase reporters (Figure 3; Figure 4A). Botox A
also lengthened the period of oscillation by approximately
1 hr (two-way ANOVA drug versus time interaction p = 0.038)
(Figure 4C). Furthermore, the relative amplitude error of
mPer2::luciferase emission was increased, reflecting less
precise circadian control over Per2 protein expression (Botox
A pretreatment = 0.033 6 0.005, posttreatment = 0.051 6
0.009; mean 6 standard error of the mean [SEM]), whereas
in vehicle-treated slices, the amplitude error declined (vehicle
pretreatment = 0.047 6 0.009, posttreatment = 0.023 6 0.003;
two-way ANOVA interaction drug versus time p = 0.024). This
long-term compromise to pacemaking was evident from video
analysis of cellular bioluminescence rhythms (Figure 5A),
which showed that the reduced amplitude of the SCN signal
and its increased error were associated with a reduction in
the amplitude of pacemaking within individual cells (Figure 5B)
plus an accompanying loss of phase coherence of oscillations
between individual SCN neurons (Figure 5C). This was re-
flected by a decrease in the mean vector in the Rayleigh test,
measured after three weeks of treatment (vehicle control
0.9636 0.008, Botox A 0.6056 0.152, t test, p = 0.04; n = 3 sli-
ces for both groups, 30–32 cells per slice). Thus, disruption ofthe endocytosis/exocytosis vesicle cycle compromised SCN
circadian pacemaking.Discussion
We have revealed clock-regulated SCN factors not previously
identified by transcriptional profiling, principally because their
abundance is regulated at stages beyond the level of mRNA
expression. The extent of circadian regulation (w6%–13% of
detectable spots) was greater than in pineal gland [22] and
retina [23] (3.4% and 2.7%, respectively). This likely reflects
our more sensitive analysis [6] and is comparable to that in
the liver [7], highlighting a common role for the circadian clock
in posttranscriptional regulation.
Our exploration of the intracellular proteome of the SCN is
different from, and complements, that of Hatcher et al. [5],
which characterized extracellular factors released from electri-
cally stimulated SCN explants. This revealed neuropeptides
implicated in intercellular signaling, and one derived from the
pro-SAAS precursor [24], which phase shifted the electrical
cycle of SCN explants, indicative of a role in retinally mediated
entrainment. Our screen identified rhythmic metabolic en-
zymes and factors involved in synaptic vesicle cycling. This
temporal orchestration of protein expression provides an effi-
cient means of sustaining the well-characterized daytime
surge in SCN metabolic rate and electrical firing [25]. For
example, our recordings reveal a circadian cycle of sponta-
neous electrical firing in mPer2::luciferase slices, ranging
between 7.4 6 1.8 Hz (mean 6 SEM, circadian day) and
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Figure 5. Chronic Inhibition of Exocytosis by Botox A Suppresses and
Desynchronizes Cellular Circadian Pacemaking in the SCN
(A) Representative bioluminescence images of SCN slice immediately
before and after 17 days of treatment with 6.7 nM Botox A. Scale bar repre-
sents 500 mm.
(B) Bioluminescence rhythms from individual cells recorded in slice (A) show
immediate damping (upper left, 47.9% +3.4%) and chronic suppression
(upper right). Expansion of the ordinate (lower right) reveals phase dispersal
of weakly rhythmic cells, which contrasts with the coherent cellular organi-
zation observed in control, vehicle-treated slices (lower left).
(C) Raster plots of cells depicted in (B) subject to vehicle (left) or chronic
Botox A (right).
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20352.4 6 0.7 Hz (circadian night). This electrical rhythm is phase
locked to the bioluminescence rhythm (M.H.H., S.R. Williams,
and S.E. Atkinson, unpublished data) and will, inevitably, be
underpinned by increased rates of vesicle recycling in the
day and a decrease during electrically quiescent circadian
night. Rhythmic expression of these factors also highlights
their potential roles as more general regulators of neuronal
functions. For example, the rhythm in NSF within the SCN is
comparable to its rhythmic expression in the retina [23],
whereas induction of sexual behavior by estrogen is associ-
ated with upregulation of NSF in the hypothalamus [26].
Changes in NSF in the SCN are accompanied by alterations
in the NSF regulator SNAP, alongside 14-3-3z and synapsin
II, all indicative of a coordinated circadian program controlling
synaptic vesicle cycling.
The importance of vesicle cycling in the pacemaker is further
highlighted by the earlybird mutation in the GTPase Rab3 [27].
Rab3 regulates synaptic vesicle transport and is essential for
the regulation of Ca2+-triggered vesicle release probability
[28]. The earlybird mutation reduces protein levels and dra-
matically accelerates the clock by w2 hr. Our biochemical
study complements this genetic analysis and focuses on
events within the active zone of the pre- and postsynaptic
membranes. Inhibiting either exocytosis or endocytosis to
compromise vesicle cycling suppressed the amplitude of
circadian gene expression. Although it is possible that off-target actions of dynasore or Botox A may contribute to this
diminution by, perhaps, compromising synthesis of GFP or
luciferase, we consider this unlikely because interference
with both axes of the vesicle cycle had the same effect, and dy-
nasore does not affect overall rates of protein synthesis [16].
Moreover, the long-term effects of Botox A in lengthening
circadian period and decreasing cellular coherence within
the SCN circuit would not arise from suppression of reporter
synthesis per se.
Contrary to earlier views of SCN neurons as robust, cell-
autonomous clocks, circuit-level properties are essential
features of pacemaking. They defend the clock against genetic
perturbation [29], and pharmacological blockade of action-
potential firing leads to loss of phase coherence and amplitude
of circadian gene expression [20, 30]. More specifically, sig-
naling by the neuropeptide vasoactive intestinal peptide
(VIP) via the VPAC2 receptor is essential for synchronized
and high-amplitude cellular pacemaking [18, 31]. Synaptic
vesicle cycling will contribute to this signaling in two ways.
First, presynaptic mechanisms will sustain the release of VIP
(and other factors) onto postsynaptic targets. Second, post-
synaptic processes will determine the endocytosis, trafficking,
and recycling of the activated G protein-coupled VPAC2
receptor. This receptor signals through adenylyl cyclase
(AC), and we have shown that inhibition of AC in the SCN phe-
nocopies the VPAC2 null mutation [32]. The rates and efficien-
cies of these pre- and postsynaptic processes will therefore
influence the dynamics of VIP/VPAC2 signaling. Thus, dyna-
sore or Botox A will dysregulate VIP-ergic (and other)
signaling, disorganizing the pacemaker circuit. Conversely,
under normal circumstances, circadian expression of vesicle
regulatory factors represents a positive adaptation to sustain
electrical firing and circuit function across the circadian cycle.
In addition to this circuit level role, we cannot rule out an
intracellular action, in which synaptic recycling itself feeds
back onto the molecular oscillator. Disruption of the endocytic
cycle by the shibirets (shits) mutation of dynamin within the
pacemaker cells of Drosophila lengthens the period of behav-
ioral rhythms and reduces levels of the positive circadian
transcription factor CLOCK within the core feedback loops
[33]. These effects can be modulated by manipulating the en-
docytic factors clathrin light chain and Rab5. Moreover, two
transcripts encoding additional components of the endocytic
pathway, syndapin and beta-adaptin, are rhythmic [34], sup-
porting the speculation [33] that circadian cycling of endocy-
tosis amplifies intercellular communication and perhaps
defines a further feedback loop in the clockwork. Finally, the
Drosophila homolog of Hsp8 (a circadian factor in the SCN)
is hsc70-4 and has been implicated in neurotransmitter exocy-
tosis [35] and clathrin-coated endocytosis, where it interacts
genetically with shibire [36]. Notwithstanding whether the
effects of disrupting endocytosis/exocytosis arise from per-
turbations of inter- or intracellular signaling, in uncovering
circadian rhythms in the expression of factors regulating
synaptic vesicle recycling and demonstrating that disruption
of these pathways compromises circadian gene expression,
we have revealed a new avenue of regulation within the SCN
pacemaker.Supplemental Data
Supplemental data include Supplemental Experimental Procedures, three
figures, and one table and can be found online at http://www.cell.com/
current-biology/supplemental/S0960-9822(09)01843-0.
Current Biology Vol 19 No 23
2036Acknowledgments
This work was supported by the Biotechnology and Biological Sciences
Research Council (UK) (grant BB/C006941/1) and the Medical Research
Council (UK). Authors are grateful to D. McMahon (Vanderbilt University),
H. Okamura (Kyoto University), and J. Takahashi (Southwestern University)
for provision of circadian reporter mice; T. Butcher (MRC, Cambridge) for
excellent technical assistance; B. Davletov (MRC, Cambridge) for advice
on the use of Botox A; and H. McMahon for advice on the use of Dynasore.
Received: June 15, 2009
Revised: October 6, 2009
Accepted: October 8, 2009
Published online: November 12, 2009
References
1. Reppert, S.M., and Weaver, D.R. (2002). Coordination of circadian
timing in mammals. Nature 418, 935–941.
2. Hastings, M.H., Reddy, A.B., and Maywood, E.S. (2003). A clockwork
web: Circadian timing in brain and periphery, in health and disease.
Nat. Rev. Neurosci. 4, 649–661.
3. Ueda, H.R., Chen, W., Adachi, A., Wakamatsu, H., Hayashi, S., Takasugi,
T., Nagano, M., Nakahama, K., Suzuki, Y., Sugano, S., et al. (2002).
A transcription factor response element for gene expression during
circadian night. Nature 418, 534–539.
4. Panda, S., Antoch, M.P., Miller, B.H., Su, A.I., Schook, A.B., Straume, M.,
Schultz, P.G., Kay, S.A., Takahashi, J.S., and Hogenesch, J.B. (2002).
Coordinated transcription of key pathways in the mouse by the circa-
dian clock. Cell 109, 307–320.
5. Hatcher, N.G., Atkins, N., Jr., Annangudi, S.P., Forbes, A.J., Kelleher,
N.L., Gillette, M.U., and Sweedler, J.V. (2008). Mass spectrometry-
based discovery of circadian peptides. Proc. Natl. Acad. Sci. USA
105, 12527–12532.
6. Karp, N.A., McCormick, P.S., Russell, M.R., and Lilley, K.S. (2007).
Experimental and statistical considerations to avoid false conclusions
in proteomics studies using differential in-gel electrophoresis. Mol.
Cell. Proteomics 6, 1354–1364.
7. Reddy, A.B., Karp, N.A., Maywood, E.S., Sage, E.A., Deery, M., O’Neill,
J.S., Wong, G.K., Chesham, J., Odell, M., Lilley, K.S., et al. (2006). Circa-
dian orchestration of the hepatic proteome. Curr. Biol. 16, 1107–1115.
8. Schwartz, W.J., and Gainer, H. (1977). Suprachiasmatic nucleus: Use of
14C-labeled deoxyglucose uptake as a functional marker. Science 197,
1089–1091.
9. Gitler, D., Cheng, Q., Greengard, P., and Augustine, G.J. (2008). Synap-
sin IIa controls the reserve pool of glutamatergic synaptic vesicles.
J. Neurosci. 28, 10835–10843.
10. Saviouk, V., Moreau, M.P., Tereshchenko, I.V., and Brzustowicz, L.M.
(2007). Association of synapsin 2 with schizophrenia in families of
Northern European ancestry. Schizophr. Res. 96, 100–111.
11. Angrand, P.O., Segura, I., Volkel, P., Ghidelli, S., Terry, R., Brajenovic,
M., Vintersten, K., Klein, R., Superti-Furga, G., Drewes, G., et al.
(2006). Transgenic mouse proteomics identifies new 14-3-3-associated
proteins involved in cytoskeletal rearrangements and cell signaling.
Mol. Cell. Proteomics 5, 2211–2227.
12. Morgan, A., and Burgoyne, R.D. (1997). Common mechanisms for
regulated exocytosis in the chromaffin cell and the synapse. Semin.
Cell Dev. Biol. 8, 141–149.
13. Kuner, T., Li, Y., Gee, K.R., Bonewald, L.F., and Augustine, G.J. (2008).
Photolysis of a caged peptide reveals rapid action of N-ethylmaleimide
sensitive factor before neurotransmitter release. Proc. Natl. Acad. Sci.
USA 105, 347–352.
14. Whiteheart, S.W., Griff, I.C., Brunner, M., Clary, D.O., Mayer, T., Buhrow,
S.A., and Rothman, J.E. (1993). SNAP family of NSF attachment proteins
includes a brain-specific isoform. Nature 362, 353–355.
15. Xu, J., Xu, Y., Ellis-Davies, G.C., Augustine, G.J., and Tse, F.W. (2002).
Differential regulation of exocytosis by alpha- and beta-SNAPs.
J. Neurosci. 22, 53–61.
16. Kirchhausen, T., Macia, E., and Pelish, H.E. (2008). Use of dynasore, the
small molecule inhibitor of dynamin, in the regulation of endocytosis.
Methods Enzymol. 438, 77–93.
17. Davletov, B., Bajohrs, M., and Binz, T. (2005). Beyond BOTOX: Advan-
tages and limitations of individual botulinum neurotoxins. Trends
Neurosci. 28, 446–452.18. Maywood, E.S., Reddy, A.B., Wong, G.K., O’Neill, J.S., O’Brien, J.A.,
McMahon, D.G., Harmar, A.J., Okamura, H., and Hastings, M.H.
(2006). Synchronization and maintenance of timekeeping in suprachias-
matic circadian clock cells by neuropeptidergic signaling. Curr. Biol.
16, 599–605.
19. Kuhlman, S.J., Quintero, J.E., and McMahon, D.G. (2000). GFP fluores-
cence reports Period 1 circadian gene regulation in the mammalian
biological clock. Neuroreport 11, 1479–1482.
20. Yamaguchi, S., Isejima, H., Matsuo, T., Okura, R., Yagita, K., Kobayashi,
M., and Okamura, H. (2003). Synchronization of cellular clocks in the
suprachiasmatic nucleus. Science 302, 1408–1412.
21. Yoo, S.H., Yamazaki, S., Lowrey, P.L., Shimomura, K., Ko, C.H., Buhr,
E.D., Siepka, S.M., Hong, H.K., Oh, W.J., Yoo, O.J., et al. (2004).
PERIOD2:LUCIFERASE real-time reporting of circadian dynamics
reveals persistent circadian oscillations in mouse peripheral tissues.
Proc. Natl. Acad. Sci. USA 101, 5339–5346.
22. Moller, M., Sparre, T., Bache, N., Roepstorff, P., and Vorum, H. (2007).
Proteomic analysis of day-night variations in protein levels in the rat
pineal gland. Proteomics 7, 2009–2018.
23. Tsuji, T., Hirota, T., Takemori, N., Komori, N., Yoshitane, H., Fukuda, M.,
Matsumoto, H., and Fukada, Y. (2007). Circadian proteomics of the
mouse retina. Proteomics 7, 3500–3508.
24. Fricker, L.D., McKinzie, A.A., Sun, J., Curran, E., Qian, Y., Yan, L.,
Patterson, S.D., Courchesne, P.L., Richards, B., Levin, N., et al. (2000).
Identification and characterization of proSAAS, a granin-like neuroen-
docrine peptide precursor that inhibits prohormone processing. J. Neu-
rosci. 20, 639–648.
25. Weaver, D.R. (1998). The suprachiasmatic nucleus: A 25-year retrospec-
tive. J. Biol. Rhythms 13, 100–112.
26. Mo, B., Callegari, E., Telefont, M., and Renner, K.J. (2008). Estrogen
regulation of proteins in the rat ventromedial nucleus of the hypothal-
amus. J. Proteome Res. 7, 5040–5048.
27. Kapfhamer, D., Valladares, O., Sun, Y., Nolan, P.M., Rux, J.J., Arnold,
S.E., Veasey, S.C., and Bucan, M. (2002). Mutations in Rab3a alter circa-
dian period and homeostatic response to sleep loss in the mouse.
Nat. Genet. 32, 290–295.
28. Schluter, O.M., Schmitz, F., Jahn, R., Rosenmund, C., and Sudhof, T.C.
(2004). A complete genetic analysis of neuronal Rab3 function. J. Neuro-
sci. 24, 6629–6637.
29. Liu, A.C., Welsh, D.K., Ko, C.H., Tran, H.G., Zhang, E.E., Priest, A.A.,
Buhr, E.D., Singer, O., Meeker, K., Verma, I.M., et al. (2007). Intercellular
coupling confers robustness against mutations in the SCN circadian
clock network. Cell 129, 605–616.
30. Maywood, E.S., O’Neill, J.S., Chesham, J.E., and Hastings, M.H. (2007).
Minireview: The circadian clockwork of the suprachiasmatic nuclei–
analysis of a cellular oscillator that drives endocrine rhythms. Endocri-
nology 148, 5624–5634.
31. Aton, S.J., Colwell, C.S., Harmar, A.J., Waschek, J., and Herzog, E.D.
(2005). Vasoactive intestinal polypeptide mediates circadian rhythmicity
and synchrony in mammalian clock neurons. Nat. Neurosci. 8, 476–483.
32. O’Neill, J.S., Maywood, E.S., Chesham, J.E., Takahashi, J.S., and
Hastings, M.H. (2008). cAMP-dependent signaling as a core component
of the mammalian circadian pacemaker. Science 320, 949–953.
33. Kilman, V.L., Zhang, L., Meissner, R.A., Burg, E., and Allada, R. (2009).
Perturbing dynamin reveals potent effects on the Drosophila circadian
clock. PLoS ONE 4, e5235.
34. Claridge-Chang, A., Wijnen, H., Naef, F., Boothroyd, C., Rajewsky, N.,
and Young, M.W. (2001). Circadian regulation of gene expression
systems in the Drosophila head. Neuron 32, 657–671.
35. Bronk, P., Wenniger, J.J., Dawson-Scully, K., Guo, X., Hong, S., Atwood,
H.L., and Zinsmaier, K.E. (2001). Drosophila Hsc70-4 is critical for neuro-
transmitter exocytosis in vivo. Neuron 30, 475–488.
36. Chang, H.C., Newmyer, S.L., Hull, M.J., Ebersold, M., Schmid, S.L., and
Mellman, I. (2002). Hsc70 is required for endocytosis and clathrin func-
tion in Drosophila. J. Cell Biol. 159, 477–487.
